全文获取类型
收费全文 | 216898篇 |
免费 | 5839篇 |
国内免费 | 532篇 |
专业分类
耳鼻咽喉 | 3031篇 |
儿科学 | 8103篇 |
妇产科学 | 6277篇 |
基础医学 | 27615篇 |
口腔科学 | 6201篇 |
临床医学 | 17510篇 |
内科学 | 39868篇 |
皮肤病学 | 4871篇 |
神经病学 | 13804篇 |
特种医学 | 11288篇 |
外国民族医学 | 99篇 |
外科学 | 32699篇 |
综合类 | 1641篇 |
一般理论 | 27篇 |
预防医学 | 18234篇 |
眼科学 | 4917篇 |
药学 | 14964篇 |
2篇 | |
中国医学 | 173篇 |
肿瘤学 | 11945篇 |
出版年
2018年 | 3911篇 |
2017年 | 4172篇 |
2016年 | 3435篇 |
2015年 | 5223篇 |
2014年 | 4802篇 |
2013年 | 4217篇 |
2012年 | 11017篇 |
2011年 | 5882篇 |
2010年 | 2891篇 |
2009年 | 4464篇 |
2008年 | 3152篇 |
2007年 | 3990篇 |
2006年 | 4275篇 |
2005年 | 12367篇 |
2004年 | 13790篇 |
2003年 | 9325篇 |
2002年 | 4524篇 |
2001年 | 4693篇 |
2000年 | 2005篇 |
1999年 | 6179篇 |
1998年 | 799篇 |
1996年 | 616篇 |
1992年 | 7129篇 |
1991年 | 7332篇 |
1990年 | 7605篇 |
1989年 | 7143篇 |
1988年 | 6695篇 |
1987年 | 6446篇 |
1986年 | 6155篇 |
1985年 | 5450篇 |
1984年 | 3810篇 |
1983年 | 3129篇 |
1982年 | 1227篇 |
1981年 | 980篇 |
1980年 | 1055篇 |
1979年 | 4040篇 |
1978年 | 2531篇 |
1977年 | 1919篇 |
1976年 | 1706篇 |
1975年 | 2603篇 |
1974年 | 3262篇 |
1973年 | 2875篇 |
1972年 | 2878篇 |
1971年 | 2843篇 |
1970年 | 2622篇 |
1969年 | 2543篇 |
1968年 | 2315篇 |
1967年 | 2238篇 |
1966年 | 1955篇 |
1965年 | 1190篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献
6.
7.
8.
Attachment is a behavioral and physiological system, which enables individual’s dynamic adaptation to its environment. Attachment develops in close interaction between an infant and his/her mother, plays an important role in the development of the infant’s brain, and influences the quality of interpersonal relationships throughout life.Security of attachment is believed to influence individual response to stress, exposing insecurely organized individuals to deregulated autonomic nervous system and exaggerated hypothalamic-pituitary-adrenal activity, which, in turn, produces increased and prolonged exposure to stress-hormones. Such stress responses may have considerable implications for the development of diverse health-risk conditions, such as insulin resistance and hyperlipidemia, shown by numerous studies.Although the mechanisms are not yet fully understood, there is compelling evidence highlighting the role of psychological stress in the development of type 1 diabetes (T1D). One of the possible contributing factors for the development of T1D may be the influence of attachment security on individual stress reactivity. Thus, the suggestion is that insecurely attached individuals are more prone to experience increased and prolonged influence of stress hormones and other mechanisms causing pancreatic beta-cell destruction.The present paper opens with a short overview of the field of attachment in children, the principal attachment classifications and their historic development, describes the influence of attachment security on individual stress-reactivity and the role of the latter in the development of T1D. Following is a review of recent literature on the attachment in patients with T1D with a conclusion of a proposed role of attachment organization in the etiology of T1D. 相似文献
9.
Torbj?rn Karlsson 《Upsala journal of medical sciences》2015,120(4):257-262
Background. Haemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by fever, hepatosplenomegaly, cytopenia, and progressive multiple-organ failure. HLH in adults is often secondary to autoimmune diseases, cancer, or infections in contrast to familial HLH. Treatment of secondary HLH is directed against the triggering disease in addition to immunosuppressive therapy, the latter commonly according to the HLH-2004 protocol.Methods. We conducted a retrospective study to identify triggering diseases, disease-specific and immunosuppressive therapy administered, and prognosis in adult patients with secondary HLH. Patient data were collected from October 2010 to January 2015.Results. Ten adult patients with secondary HLH were identified. Seven were men, and the median age at diagnosis was 62 years. Five cases were triggered by malignant disease and five by infection. The median patient fulfilled five of the eight HLH-2004 diagnostic criteria. All patients fulfilled the criteria fever, cytopenia, and ferritin >500 µg/L. Median time from hospital admission to HLH diagnosis was 20 days. Four patients received immunosuppressive therapy according to the HLH-2004 protocol. The prognosis was dismal, especially for the patients with malignancy-associated HLH, of whom all died.Conclusion. HLH should be suspected in patients who present with fever, cytopenia, and ferritin >500 µg/L. Secondary HLH has a dismal prognosis. None of the patients with HLH triggered by malignancy survived. Achieving remission of the triggering disease seems to be important for a favourable outcome as, in all surviving patients, the haemophagocytic syndrome resolved after remission of the underlying infection. 相似文献
10.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献